{"id":"W4411470437","doi":"10.51731/cjht.2025.1149","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Endometrial cancer; Paclitaxel; Carcinosarcoma; Oncology; Internal medicine; Stage (stratigraphy); Pembrolizumab; Carcinoma; Cancer; Gynecology; Chemotherapy; Cisplatin; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002598696,0.0001703525,0.0002524335,0.0003309784,0.0003153804,0.0004819305,0.0003140165,0.0004703409,0.01125757],"category_scores_gemma":[0.0004847819,0.00007754091,0.0002347584,0.0002297927,0.0001275418,0.0003499618,0.0002576812,0.001203411,0.002779147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009529087,"about_ca_system_score_gemma":0.0009349858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008213103,"about_ca_topic_score_gemma":0.01979126,"domain_scores_codex":[0.9998549,0.00001781559,0.00001002883,0.00002463046,0.00005413352,0.00003847255],"domain_scores_gemma":[0.9998831,0.00001531794,0.00002126345,0.000006310498,0.00003043526,0.0000437184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001774368,0.0003473382,0.001586499,0.0008910073,0.00009329629,0.0006946176,0.00004999466,0.0002744438,0.01378458,0.002746681,0.1153631,0.8623941],"study_design_scores_gemma":[0.002476268,0.001731767,0.01206217,0.0006604522,0.0001407162,0.003700339,0.00004661519,0.0004559665,0.006641953,0.001038561,0.97102,0.00002508928],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.1311466,0.3966115,0.00654526,0.03829682,0.003344436,0.001225722,0.006540019,0.001513206,0.4147764],"genre_scores_gemma":[0.6690119,0.1269124,0.010499,0.01726048,0.001154328,0.0006926372,0.006178373,0.00008568379,0.1682052],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.01125757,"threshold_uncertainty_score":0.0376603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02653310924636881,"score_gpt":0.3248716199295898,"score_spread":0.298338510683221,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}